The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis
Journal article published in 2019 by
Michael Trauner,
Aliya Gulamhusein,
Bilal Hameed,
Stephen Caldwell,
Mitchell L. Shiffman,
Charles Landis,
Bertus Eksteen,
Kosh Agarwal 
,
Andrew Muir,
Simon Rushbrook,
Xiaomin Lu,
Jun Xu,
Jen‐Chieh Chuang,
Andrew N. Billin,
Georgia Li
and other authors.
,
Andrew Muir,
Simon Rushbrook,
Xiaomin Lu,
Jun Xu,
Jen‐Chieh Chuang,
Andrew N. Billin,
Georgia Li
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 